Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  A large fraction of HLA class I ligands are proteasome-generated spliced peptides.

Liepe, J., Marino, F., Sidney, J., Jeko, A., Bunting, D. E., Sette, A., et al. (2016). A large fraction of HLA class I ligands are proteasome-generated spliced peptides. Science, 354(6310), 354-358. doi:10.1126/science.aaf4384.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
2472947.pdf (Verlagsversion), 739KB
 
Datei-Permalink:
-
Name:
2472947.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Eingeschränkt (UNKNOWN id 303; )
MIME-Typ / Prüfsumme:
application/pdf
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
-
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Liepe, J.1, Autor           
Marino, F., Autor
Sidney, J., Autor
Jeko, A., Autor
Bunting, D. E., Autor
Sette, A., Autor
Kloetzel, P. M., Autor
Stumpf, M.l P. H., Autor
Heck, A. J. R., Autor
Mishto, M., Autor
Affiliations:
1Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society, ou_2466694              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: The proteasome generates the epitopes presented on human leukocyte antigen (HLA) class I molecules that elicit CD8+ T cell responses. Reports of proteasome-generated spliced epitopes exist, but they have been regarded as rare events. Here, however, we show that the proteasome-generated spliced peptide pool accounts for one-third of the entire HLA class I immunopeptidome in terms of diversity and one-fourth in terms of abundance. This pool also represents a unique set of antigens, possessing particular and distinguishing features. We validated this observation using a range of complementary experimental and bioinformatics approaches, as well as multiple cell types. The widespread appearance and abundance of proteasome-catalyzed peptide splicing events has implications for immunobiology and autoimmunity theories and may provide a previously untapped source of epitopes for use in vaccines and cancer immunotherapy.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2016-10-21
 Publikationsstatus: Online veröffentlicht
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1126/science.aaf4384
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Science
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 354 (6310) Artikelnummer: - Start- / Endseite: 354 - 358 Identifikator: -